ArticleAmerican journal of cancer research2011

Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects.

Mohammad A Shahshahan et al.PubMed ↗Full text ↗

No numbers read from the abstract.